The Safety and Efficacy of Long-term Treatment of PINS Stimulator System for Patients With Alzheimer's Disease
- Conditions
- Alzheimer's Disease
- Interventions
- Device: Deep Brain Stimulation (Beijing PINS Medical Co., Ltd)
- Registration Number
- NCT02253043
- Lead Sponsor
- Beijing Pins Medical Co., Ltd
- Brief Summary
Purpose: The purpose of this clinical study is to verify the long term effectiveness and safety of a bilateral deep brain stimulation (DBS) produced by Beijing PINS Medical Co., Ltd. as a treatment option for patients with cognitive, behavioral, and functional disability of Alzheimer's disease.
- Detailed Description
Other: Deep Brain Stimulation Implanted device Subjects will then be instructed to apply PINS Deep Brain Stimulation Device for 12 month.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 10
- Subject is aged 40 to 80 years old;
- Subject with AD diagnosed according to the criteria for probable AD as defined by the National Institute of Neurological Disorders and Stroke-Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA);
- Subject have received the diagnosis of AD within the past 2 years;
- Subject have a CDR of 0.5 or 1.0;
- Score between 20 and 28 on the Mini Mental State Examination
- have been taking a stable dose of cholinesterase inhibitors for a minimum of 6 months.
- Patients with hearing impairment;
- Failures of important organs and in severe conditions
- Be reluctant or disabled to receive neuropsychological assessments;
- Participate in other clinical trial;
- Has a life expectancy of < 1 year.
- The investigator and/or enrollment review committee, would preclude participation in the study.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Deep Brain Stimulation Deep Brain Stimulation (Beijing PINS Medical Co., Ltd) DBS Implant and stimulation
- Primary Outcome Measures
Name Time Method Alzheimer's Disease Assessment Scale, Cognitive Subscale (ADAS-Cog) 12 month Change from Baseline
- Secondary Outcome Measures
Name Time Method Clinical Dementia Rating Scale 12 month Change from Baseline
Trial Locations
- Locations (2)
301 Hospatl
🇨🇳Beijing, Beijing, China
Beijing Tiantan Hospital
🇨🇳Beijing, Beijing, China